Annual EBIT:
$5.30B-$3.15B(-37.28%)Summary
- As of today, GSK annual earnings before interest & taxes is $5.30 billion, with the most recent change of -$3.15 billion (-37.28%) on December 31, 2024.
- During the last 3 years, GSK annual EBIT has fallen by -$703.62 million (-11.72%).
- GSK annual EBIT is now -69.21% below its all-time high of $17.21 billion, reached on December 31, 2015.
Performance
GSK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$3.47B+$1.18B(+51.41%)Summary
- As of today, GSK quarterly earnings before interest & taxes is $3.47 billion, with the most recent change of +$1.18 billion (+51.41%) on September 1, 2025.
- Over the past year, GSK quarterly EBIT has increased by +$2.85 billion (+460.19%).
- GSK quarterly EBIT is now -12.60% below its all-time high of $3.97 billion, reached on December 31, 2000.
Performance
GSK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$9.88B+$2.85B(+40.49%)Summary
- As of today, GSK TTM earnings before interest & taxes is $9.88 billion, with the most recent change of +$2.85 billion (+40.49%) on September 1, 2025.
- Over the past year, GSK TTM EBIT has increased by +$2.63 billion (+36.26%).
- GSK TTM EBIT is now -34.10% below its all-time high of $14.99 billion, reached on June 30, 2008.
Performance
GSK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GSK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -37.3% | +460.2% | +36.3% |
| 3Y3 Years | -11.7% | +40.0% | +26.7% |
| 5Y5 Years | -41.5% | +17.3% | +9.0% |
GSK EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -37.3% | at low | at high | +460.2% | at high | +40.5% |
| 5Y | 5-Year | -41.5% | at low | at high | +460.2% | at high | +40.5% |
| All-Time | All-Time | -69.2% | >+9999.0% | -12.6% | +162.0% | -34.1% | >+9999.0% |
GSK EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $3.47B(+51.4%) | $9.88B(+40.5%) |
| Jun 2025 | - | $2.29B(-15.0%) | $7.03B(-3.0%) |
| Mar 2025 | - | $2.69B(+88.2%) | $7.25B(+2.5%) |
| Dec 2024 | $5.30B(-37.3%) | $1.43B(+131.3%) | $7.07B(-2.5%) |
| Sep 2024 | - | $618.81M(-75.3%) | $7.25B(-23.4%) |
| Jun 2024 | - | $2.50B(-0.4%) | $9.47B(+4.3%) |
| Mar 2024 | - | $2.51B(+55.8%) | $9.08B(+4.8%) |
| Dec 2023 | $8.45B(+5.7%) | $1.61B(-43.2%) | $8.67B(+5.9%) |
| Sep 2023 | - | $2.84B(+34.5%) | $8.19B(+4.7%) |
| Jun 2023 | - | $2.11B(+0.5%) | $7.82B(+1.7%) |
| Mar 2023 | - | $2.10B(+85.2%) | $7.69B(-0.7%) |
| Dec 2022 | $7.99B(+33.2%) | $1.13B(-54.2%) | $7.74B(-0.7%) |
| Sep 2022 | - | $2.48B(+25.0%) | $7.80B(+3.4%) |
| Jun 2022 | - | $1.98B(-8.0%) | $7.54B(+0.8%) |
| Mar 2022 | - | $2.15B(+81.3%) | $7.49B(+1.1%) |
| Dec 2021 | $6.00B(-22.3%) | $1.19B(-46.6%) | $7.41B(-9.0%) |
| Sep 2021 | - | $2.22B(+15.5%) | $8.14B(-8.3%) |
| Jun 2021 | - | $1.92B(-7.2%) | $8.88B(+2.8%) |
| Mar 2021 | - | $2.07B(+7.9%) | $8.64B(-8.7%) |
| Dec 2020 | $7.72B(-14.8%) | $1.92B(-35.0%) | $9.47B(+4.4%) |
| Sep 2020 | - | $2.96B(+75.5%) | $9.06B(+2.2%) |
| Jun 2020 | - | $1.68B(-41.9%) | $8.87B(-6.3%) |
| Mar 2020 | - | $2.90B(+90.8%) | $9.47B(+5.9%) |
| Dec 2019 | $9.07B(+23.7%) | $1.52B(-44.9%) | $8.94B(-5.6%) |
| Sep 2019 | - | $2.76B(+20.8%) | $9.48B(+2.5%) |
| Jun 2019 | - | $2.29B(-3.9%) | $9.25B(+0.9%) |
| Mar 2019 | - | $2.38B(+15.8%) | $9.16B(+1.4%) |
| Dec 2018 | $7.33B(+33.2%) | $2.05B(-18.8%) | $9.03B(+3.2%) |
| Sep 2018 | - | $2.53B(+15.0%) | $8.75B(+1.5%) |
| Jun 2018 | - | $2.20B(-2.2%) | $8.63B(+10.8%) |
| Mar 2018 | - | $2.25B(+26.6%) | $7.79B(+6.0%) |
| Dec 2017 | $5.50B(+52.9%) | $1.78B(-26.0%) | $7.35B(+1.3%) |
| Sep 2017 | - | $2.40B(+76.6%) | $7.25B(+0.5%) |
| Jun 2017 | - | $1.36B(-24.8%) | $7.22B(-11.4%) |
| Mar 2017 | - | $1.81B(+7.3%) | $8.15B(-0.9%) |
| Dec 2016 | $3.60B(-79.1%) | $1.68B(-28.8%) | $8.22B(+33.7%) |
| Sep 2016 | - | $2.37B(+3.4%) | $6.15B(+7.0%) |
| Jun 2016 | - | $2.29B(+21.8%) | $5.75B(+9.4%) |
| Mar 2016 | - | $1.88B(+587.9%) | $5.26B(+5.1%) |
| Dec 2015 | $17.21B(+184.4%) | -$385.22M(-119.6%) | $5.00B(-36.6%) |
| Sep 2015 | - | $1.97B(+9.5%) | $7.89B(-9.0%) |
| Jun 2015 | - | $1.80B(+10.4%) | $8.67B(-2.3%) |
| Mar 2015 | - | $1.63B(-34.9%) | $8.87B(-5.5%) |
| Dec 2014 | $6.05B(-47.6%) | $2.50B(-9.1%) | $9.39B(+36.2%) |
| Sep 2014 | - | $2.75B(+37.2%) | $6.89B(-1.4%) |
| Jun 2014 | - | $2.00B(-6.7%) | $6.99B(-8.5%) |
| Mar 2014 | - | $2.14B(>+9900.0%) | $7.64B(-5.7%) |
| Dec 2013 | $11.56B(-0.9%) | $0.00(-100.0%) | $8.10B(-29.0%) |
| Sep 2013 | - | $2.84B(+7.2%) | $11.40B(+1.0%) |
| Jun 2013 | - | $2.65B(+1.9%) | $11.29B(-3.6%) |
| Mar 2013 | - | $2.60B(-21.2%) | $11.72B(-1.6%) |
| Dec 2012 | $11.66B(-14.0%) | $3.30B(+21.0%) | $11.91B(+38.4%) |
| Sep 2012 | - | $2.73B(-11.3%) | $8.61B(-5.8%) |
| Jun 2012 | - | $3.08B(+10.1%) | $9.13B(-0.3%) |
| Mar 2012 | - | $2.80B(>+9900.0%) | $9.16B(-1.8%) |
| Dec 2011 | $13.56B(+123.1%) | $0.00(-100.0%) | $9.33B(+33.9%) |
| Sep 2011 | - | $3.26B(+4.8%) | $6.97B(+5.3%) |
| Jun 2011 | - | $3.11B(+4.7%) | $6.62B(+90.9%) |
| Mar 2011 | - | $2.97B(+225.8%) | $3.47B(+1.1%) |
| Dec 2010 | $6.08B(-55.3%) | -$2.36B(-181.3%) | $3.43B(-63.0%) |
| Sep 2010 | - | $2.91B(+6586.0%) | $9.26B(-4.1%) |
| Jun 2010 | - | -$44.80M(-101.5%) | $9.66B(-23.1%) |
| Mar 2010 | - | $2.93B(-15.6%) | $12.57B(+1.4%) |
| Dec 2009 | $13.59B(-2.1%) | $3.47B(+5.1%) | $12.39B(+3.8%) |
| Sep 2009 | - | $3.30B(+15.5%) | $11.94B(+38.3%) |
| Jun 2009 | - | $2.86B(+3.9%) | $8.63B(-9.7%) |
| Mar 2009 | - | $2.76B(-8.7%) | $9.57B(-9.4%) |
| Dec 2008 | $13.87B(-15.5%) | $3.02B(>+9900.0%) | $10.56B(-6.0%) |
| Sep 2008 | - | $0.00(-100.0%) | $11.24B(-25.0%) |
| Jun 2008 | - | $3.79B(+1.1%) | $14.99B(+1.0%) |
| Mar 2008 | - | $3.75B(+1.6%) | $14.84B(-0.5%) |
| Dec 2007 | $16.41B(+14.0%) | $3.69B(-1.6%) | $14.92B(+4.4%) |
| Sep 2007 | - | $3.75B(+3.2%) | $14.29B(+0.9%) |
| Jun 2007 | - | $3.64B(-4.9%) | $14.15B(+1.6%) |
| Mar 2007 | - | $3.83B(+25.0%) | $13.93B(+1.0%) |
| Dec 2006 | $14.39B(+2074.0%) | $3.06B(-15.4%) | $13.78B(+2.0%) |
| Sep 2006 | - | $3.62B(+6.2%) | $13.52B(+6.0%) |
| Jun 2006 | - | $3.41B(-7.4%) | $12.75B(+2.0%) |
| Mar 2006 | - | $3.69B(+31.7%) | $12.51B(+5.6%) |
| Dec 2005 | $661.92M | $2.80B(-2.0%) | $11.85B(+5.6%) |
| Sep 2005 | - | $2.86B(-9.9%) | $11.22B(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2005 | - | $3.17B(+4.7%) | $11.03B(+5.3%) |
| Mar 2005 | - | $3.03B(+39.7%) | $10.48B(+2.8%) |
| Dec 2004 | $10.54B(+1.0%) | $2.17B(-18.8%) | $10.19B(-0.6%) |
| Sep 2004 | - | $2.67B(+2.0%) | $10.25B(-2.5%) |
| Jun 2004 | - | $2.61B(-4.7%) | $10.51B(-3.9%) |
| Mar 2004 | - | $2.74B(+23.4%) | $10.93B(-1.1%) |
| Dec 2003 | $10.44B(+21.6%) | $2.22B(-24.1%) | $11.05B(-4.0%) |
| Sep 2003 | - | $2.93B(-3.5%) | $11.51B(+6.9%) |
| Jun 2003 | - | $3.04B(+6.0%) | $10.76B(+6.3%) |
| Mar 2003 | - | $2.86B(+6.9%) | $10.13B(+8.7%) |
| Dec 2002 | $8.58B(-2.4%) | $2.68B(+22.7%) | $9.32B(+8.9%) |
| Sep 2002 | - | $2.18B(-8.9%) | $8.56B(+2.8%) |
| Jun 2002 | - | $2.40B(+16.8%) | $8.32B(+2.0%) |
| Mar 2002 | - | $2.05B(+6.9%) | $8.16B(+0.3%) |
| Dec 2001 | $8.79B(-8.6%) | $1.92B(-1.5%) | $8.14B(-20.1%) |
| Sep 2001 | - | $1.95B(-12.8%) | $10.18B(+2.9%) |
| Jun 2001 | - | $2.24B(+10.1%) | $9.89B(+2.4%) |
| Mar 2001 | - | $2.03B(-48.8%) | $9.66B(+1.5%) |
| Dec 2000 | $9.62B(+113.7%) | $3.97B(+138.9%) | $9.52B(>+9900.0%) |
| Sep 2000 | - | $1.66B(-17.2%) | -$41.95M(-102.2%) |
| Jun 2000 | - | $2.00B(+6.4%) | $1.94B(+88.5%) |
| Mar 2000 | - | $1.88B(+133.7%) | $1.03B(-57.6%) |
| Dec 1999 | $4.50B(-5.5%) | -$5.59B(-253.4%) | $2.43B(-16.7%) |
| Sep 1999 | - | $3.65B(+233.8%) | $2.92B(+9.2%) |
| Jun 1999 | - | $1.09B(-66.8%) | $2.67B(+3.1%) |
| Mar 1999 | - | $3.29B(+164.4%) | $2.59B(+4.3%) |
| Dec 1998 | $4.76B(-0.2%) | -$5.11B(-250.1%) | $2.49B(+11.3%) |
| Sep 1998 | - | $3.40B(+236.4%) | $2.23B(+7.0%) |
| Jun 1998 | - | $1.01B(-68.2%) | $2.09B(-52.2%) |
| Mar 1998 | - | $3.18B(+159.3%) | $4.37B(-3.5%) |
| Dec 1997 | $4.77B(-5.7%) | -$5.36B(-264.7%) | $4.53B(-35.7%) |
| Sep 1997 | - | $3.25B(-1.1%) | $7.04B(-8.0%) |
| Jun 1997 | - | $3.29B(-1.4%) | $7.65B(+1.4%) |
| Mar 1997 | - | $3.34B(+217.3%) | $7.55B(+1.1%) |
| Dec 1996 | $5.06B(+17.7%) | -$2.85B(-173.6%) | $7.47B(-27.6%) |
| Sep 1996 | - | $3.87B(+21.3%) | $10.31B(+14.5%) |
| Jun 1996 | - | $3.19B(-2.1%) | $9.01B(+1745.6%) |
| Mar 1996 | - | $3.26B(+27.0%) | $488.17M(-79.4%) |
| Dec 1995 | $4.30B(+52.9%) | - | - |
| Sep 1995 | - | $2.56B(+148.1%) | $2.37B(+1.4%) |
| Jun 1995 | - | -$5.33B(-310.9%) | $2.34B(-41.0%) |
| Mar 1995 | - | $2.53B(-3.3%) | $3.97B(+7.2%) |
| Dec 1994 | - | $2.61B(+3.3%) | $3.70B(+15.4%) |
| Sep 1994 | - | $2.53B(+168.3%) | $3.21B(+15.8%) |
| Jun 1994 | $2.81B(-0.0%) | -$3.71B(-263.9%) | $2.77B(-14.6%) |
| Mar 1994 | - | $2.26B(+6.6%) | $3.24B(+1.0%) |
| Dec 1993 | - | $2.12B(+1.3%) | $3.21B(+10.8%) |
| Sep 1993 | - | $2.09B(+164.8%) | $2.90B(+8.7%) |
| Jun 1993 | $2.81B(+7.3%) | -$3.23B(-245.0%) | $2.66B(+5.8%) |
| Mar 1993 | - | $2.23B(+23.3%) | $2.52B(+10.9%) |
| Dec 1992 | - | $1.81B(-2.9%) | $2.27B(-1.8%) |
| Sep 1992 | - | $1.86B(+155.1%) | $2.31B(-0.5%) |
| Jun 1992 | $2.62B(+4.0%) | -$3.38B(-270.5%) | $2.33B(-41.3%) |
| Mar 1992 | - | $1.98B(+7.2%) | $3.96B(+13.4%) |
| Dec 1991 | - | $1.85B(-1.3%) | $3.49B(+15.1%) |
| Sep 1991 | - | $1.87B(+207.3%) | $3.03B(+19.9%) |
| Jun 1991 | $2.52B(+26.3%) | -$1.75B(-215.4%) | $2.53B(-0.9%) |
| Mar 1991 | - | $1.51B(+8.7%) | $2.55B(+9.2%) |
| Dec 1990 | - | $1.39B(+1.5%) | $2.34B(+9.3%) |
| Sep 1990 | - | $1.37B(+179.5%) | $2.14B(+9.4%) |
| Jun 1990 | $2.00B(+12.7%) | -$1.72B(-232.7%) | $1.96B(-20.5%) |
| Mar 1990 | - | $1.30B(+8.8%) | $2.46B(+12.8%) |
| Dec 1989 | - | $1.19B(+0.5%) | $2.18B(+9.3%) |
| Sep 1989 | - | $1.19B(+197.3%) | $1.99B(+9.3%) |
| Jun 1989 | $1.77B(+18.4%) | -$1.22B(-219.8%) | $1.82B(-9.2%) |
| Mar 1989 | - | $1.02B(+1.1%) | $2.01B(+8.3%) |
| Dec 1988 | - | $1.01B(-1.1%) | $1.85B(+11.6%) |
| Sep 1988 | - | $1.02B(+198.4%) | $1.66B(+10.4%) |
| Jun 1988 | $1.50B(+29.6%) | -$1.03B(-219.8%) | $1.51B(-10.5%) |
| Mar 1988 | - | $863.72M(+6.1%) | $1.68B(+9.7%) |
| Dec 1987 | - | $814.42M(-5.5%) | $1.53B(+13.5%) |
| Sep 1987 | - | $862.23M(+200.4%) | $1.35B(+16.3%) |
| Jun 1987 | $1.15B(+29.5%) | -$858.44M(-220.2%) | $1.16B(-7.3%) |
| Mar 1987 | - | $714.30M(+12.9%) | $1.25B(+15.9%) |
| Dec 1986 | - | $632.59M(-6.0%) | $1.08B(+8.4%) |
| Sep 1986 | - | $672.76M(+187.7%) | $995.94M(+15.3%) |
| Jun 1986 | $891.48M(>+9900.0%) | -$767.31M(-241.6%) | $863.62M(-47.0%) |
| Mar 1986 | - | $542.04M(-1.2%) | $1.63B(+49.8%) |
| Dec 1985 | - | $548.45M(+1.5%) | $1.09B(+101.5%) |
| Sep 1985 | - | $540.44M | $540.44M |
| Jun 1985 | $0.00(0.0%) | - | - |
| Jun 1984 | $0.00 | - | - |
FAQ
- What is GSK plc annual earnings before interest & taxes?
- What is the all-time high annual EBIT for GSK plc?
- What is GSK plc annual EBIT year-on-year change?
- What is GSK plc quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for GSK plc?
- What is GSK plc quarterly EBIT year-on-year change?
- What is GSK plc TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for GSK plc?
- What is GSK plc TTM EBIT year-on-year change?
What is GSK plc annual earnings before interest & taxes?
The current annual EBIT of GSK is $5.30B
What is the all-time high annual EBIT for GSK plc?
GSK plc all-time high annual earnings before interest & taxes is $17.21B
What is GSK plc annual EBIT year-on-year change?
Over the past year, GSK annual earnings before interest & taxes has changed by -$3.15B (-37.28%)
What is GSK plc quarterly earnings before interest & taxes?
The current quarterly EBIT of GSK is $3.47B
What is the all-time high quarterly EBIT for GSK plc?
GSK plc all-time high quarterly earnings before interest & taxes is $3.97B
What is GSK plc quarterly EBIT year-on-year change?
Over the past year, GSK quarterly earnings before interest & taxes has changed by +$2.85B (+460.19%)
What is GSK plc TTM earnings before interest & taxes?
The current TTM EBIT of GSK is $9.88B
What is the all-time high TTM EBIT for GSK plc?
GSK plc all-time high TTM earnings before interest & taxes is $14.99B
What is GSK plc TTM EBIT year-on-year change?
Over the past year, GSK TTM earnings before interest & taxes has changed by +$2.63B (+36.26%)